TRANSLATE

The all Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the all Hub cannot guarantee the accuracy of translated content. The all and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

The ALL Hub is an independent medical education platform, sponsored by Jazz Pharmaceuticals, Amgen, and Pfizer and supported through an educational grant from Servier. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.

Now you can support HCPs in making informed decisions for their patients

Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.

Find out more
 Wendy Stock

Wendy Stock

Steering Committee Member

Wendy Stock is a professor of medicine specializing in hematology/oncology at the University of Chicago, US. Her areas of expertise include acute leukemia, chronic lymphocytic leukemia, chronic myeloid leukemia, myelodysplastic syndromes, adolescent and young adult cancer care, CAR (chimeric antigen receptor) T-cell therapy, and stem cell transplant. Wendy is a co-leader of the University of Chicago Cancer Research Center’s Program in Hematopoiesis and Hematological Malignancies and is a core member of the Leukemia and Leukemia Correlative Sciences Committees in the Alliance, a NCI-sponsored clinical trials cooperative group. Additionally, Wendy is co-chair of the NCI National Clinical Trials Network (NCTN) Leukemia Steering Committee.

Filter by content: